A Comparative Study of Aminosidine Sulfate, Meglomine Antimoniate, Combination of both and Glucantime in Murine Leishmaniasis Treatment of Cutaneous Leishmaniasis, Caused by Leishmania tropica, with Topical Application of Paromomycin 20% in BALB-c Mice
| Author | Mohammad Shahidi Dadras | en |
| Author | Afshin Mirzaei | en |
| Author | Bahram Kazemi | en |
| Author | Leyla Nabai | en |
| Author | Ali Sharifian | en |
| Issued Date | 2007-07-31 | en |
| Abstract | The current treatment of choice for cutaneous leishmaniasis is either parenteral or intralesional antimonial compounds. Each of these treatments has its own downfalls which include toxic side effects with the parentral injection and pain at the site of injection with the intralesional injection. In recent years, there has been more focus on Paromomycin as an alternative drug; however, current data arose many controversies. | en |
| DOI | https://doi.org/10.22037/ijpr.2010.723 | en |
| Keyword | Paromomycin | en |
| Keyword | meglumine antimoniate | en |
| Keyword | Gentamycin | en |
| Keyword | Cutaneous leishmaniasis | en |
| Keyword | BALB/c mice | en |
| Publisher | Brieflands | en |
| Title | A Comparative Study of Aminosidine Sulfate, Meglomine Antimoniate, Combination of both and Glucantime in Murine Leishmaniasis Treatment of Cutaneous Leishmaniasis, Caused by Leishmania tropica, with Topical Application of Paromomycin 20% in BALB-c Mice | en |
| Type | Research Article | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- article_723_7543338b7805d9209779f159a21e2c90.pdf
- Size:
- 509.62 KB
- Format:
- Adobe Portable Document Format
- Description:
- Article/s PDF